Menlo Park, CA · Founded 2014 · Privately Held (backing)
Operator of a biomarker-driven precision medicine company intended to improve monitoring and treatment decisions for neurodegenerative diseases. Octave Bioscience is based in Menlo Park, CA and was founded in 2014. Its last reported valuation was $143 million in Jul 2023. It has raised $129 million across 5 recorded rounds; the latest was a $31.8 million early-stage round in Mar 2025.
Last reported valuation
$143.0M
Oct 2026
Priced at
—
Total raised
$129.2M
Last round
Early Stage VC
Mar 2025
Team — not yet on record
No current team members for Octave Bioscience are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Octave Bioscience with a free account
·The complete investor list: 18 names
·Watch Octave Bioscience: the Monday email on marks, rounds and moves
